ArticleHealth care science2024
A novel ensemble ARIMA-LSTM approach for evaluating COVID-19 cases and future outbreak preparedness.
Article in Health care science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Real-time dynamic prediction of HFMD transmission using SEIRQ-ARIMA hybrid model optimized by multi-stage ABC-GWO algorithm.Scientific reports · 2026Article
- A Hybrid Framework Integrating Traditional Models and Deep Learning for Multi-Scale Time Series Forecasting.Entropy (Basel, Switzerland) · 2025Article
- Intelligent prediction of thyroid cancer in China based on GBD data and hospital electronic medical records: disease burden analysis combined with multiple machine learning models.Frontiers in endocrinology · 2025Article
- Hybrid ARIMA-LSTM for COVID-19 forecasting: a comparative AI modeling study.PeerJ. Computer science · 2025Article
- Application and comparison of ARIMA, LSTM, and ARIMA-LSTM models for predicting foodborne diseases in Liaoning Province.Frontiers in big data · 2025Article
- A novel ensemble ARIMA-LSTM approach for evaluating COVID-19 cases and future outbreak preparedness.Health care science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The global impact of the highly contagious COVID-19 virus has created unprecedented challenges, significantly impacting public health and economies worldwide. This research article conducts a time series analysis of COVID-19 data across various countries, including India, Brazil, Russia, and the United States, with a particular emphasis on total confirmed cases. Methods: The proposed approach combines auto-regressive integrated moving average (ARIMA)'s ability to capture linear trends and seasonality with long short-term memory (LSTM) networks, which are designed to learn complex nonlinear dependencies in the data. This hybrid approach surpasses both individual models and existing ARIMA-artificial neural network (ANN) hybrids, which often struggle with highly nonlinear time series like COVID-19 data. By integrating ARIMA and LSTM, the model aims to achieve superior forecasting accuracy compared to baseline models, including ARIMA, Gated Recurrent Unit (GRU), LSTM, and Prophet. Results: The hybrid ARIMA-LSTM model outperformed the benchmark models, achieving a mean absolute percentage error (MAPE) score of 2.4%. Among the benchmark models, GRU performed the best with a MAPE score of 2.9%, followed by LSTM with a score of 3.6%. Conclusions: The proposed ARIMA-LSTM hybrid model outperforms ARIMA, GRU, LSTM, Prophet, and the ARIMA-ANN hybrid model when evaluating using metrics like MAPE, symmetric mean absolute percentage error, and median absolute percentage error across all countries analyzed. These findings have the potential to significantly improve preparedness and response efforts by public health authorities, allowing for more efficient resource allocation and targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.